Home > Insider Trading > Filing (0001209191-20-054284)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1706431	Vir Biotechnology Inc.	VIR	Biological Products, (No Disgnostic Substances) (2836)	812730369

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787370	Phillip Pang	C/O Vir Biotechnology, Inc. 499 Illinois Street, Suite 500 San Francisco CA 94158	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-07	10,185	$1.53	39,962	No	4	M	Direct
Common Stock	Acquisiton	2020-10-07	2,315	$1.58	42,277	No	4	M	Direct
Common Stock	Disposition	2020-10-07	7,500	$41.76	34,777	No	4	S	Direct
Common Stock	Disposition	2020-10-07	5,000	$41.73	29,777	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2020-10-07	10,185	$0.00	10,185	$1.53
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2020-10-07	2,315	$0.00	2,315	$1.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,461		2028-04-27	No	4	M	Direct
50,927		2028-07-19	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.